TECO Energy Announces Pricing of Public Offering of Common Stock

Targeted News Service |

TAMPA, Fla., July 1 -- TECO Energy issued the following news release: TECO Energy, Inc. (NYSE:TE) today reported that it has entered into an underwriting agreement for the sale by the company of 15.5 million primary shares of its common stock pursuant to an effective shelf registration statement at a price to the public of $18.10 per share through underwriters led by Morgan Stanley, Citigroup and JP Morgan as joint bookrunning managers. The offering is expected to close on or about July 8, 2014, subject to customary closing conditions. Net proceeds from the sale are expected to be about $271 million after expenses and will be used to fund, in part, TECO Energy's acquisition of New Mexico Gas Co. and for general corporate purposes. TECO Energy has also granted the underwriters an option for a period of 30 days to purchase an additional 2,325,000 shares of common stock on the same terms and conditions. This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities law of any state or jurisdiction. The offering is being made only by means of a prospectus supplement and accompanying prospectus forming a part of the effective registration statement. A copy of the preliminary prospectus supplement and accompanying prospectus relating to this offering may be obtained from the offices of Morgan Stanley, Prospectus Department, 180 Varick Street 2nd Floor, New York, New York 10014, Citigroup Global Markets, Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717 or J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717. An electronic copy of the final prospectus supplement and accompanying prospectus will be available from the Securities and Exchange Commission's web site at www.sec.gov. CC AutoTriage10PkS-140702-30TacordaCheng-4786125 30TacordaCheng

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
CDFRF Consolidated Infrastructure Group Ltd. n/a n/a n/a 0

Comments

Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

WayBetter

The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…

Wealthfront

Wealthfront is an automated investment service that serves as an alternative to traditional financial advisory services. The company manages a diversified, continually rebalanced portfolio of index funds on their clients’…